FC2 Female Condom®

Home

How to Use FC2

How to Get FC2

FAQs

Quick Facts

Health Professionals

Resources

Training Material

Advocacy

FC2 Experience Program

Key Events

FC2 in the News

City Program Information

FC2 Research

Contact Us

  • Female-initiated Prevention: Integrating Female Condoms into HIV Risk-reduction Activities in Kenya
Population Council: Martha Brady (Principal Investigator), Karen Austrian, Scott Geibel, Dianah Mwangi, S. Sudha
Liverpool VCT, Care & Treatment: Nduku Kilonzo (Principal Investigator), Hawa Ngari, Elizabeth Njoki, Gloria Khisa, Carol Ajema, Family Health Options of Kenya Del Monte (K) Ltd., Unilever, Ltd., Published: March 2009


  • FDA notifications. FC2 female condom receives FDA approval.
[No authors listed]  AIDS Alert. 2009 May;24(5):58-9. No abstract available.



  • Male partner involvement and assistance in female condom use.

Beksinska M, Smit J, Mabude Z, Vijayakumar G, Linda J.

Eur J Contracept Reprod Health Care. 2008 Dec;13(4):400-3.
  • Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.

Dowdy DW, Sweat MD, Holtgrave DR.

AIDS. 2006 Oct 24;20(16):2091-8.


  • Short-term acceptability of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women.

Smit J, Beksinska M, Vijayakumar G, Mabude Z.

Contraception. 2006 Apr;73(4):394-8. Epub 2006 Feb 3.


  • Performance of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women.

Beksinska M, Smit J, Mabude Z, Vijayakumar G, Joanis C.

Contraception. 2006 Apr;73(4):386-93. Epub 2005 Oct 19
                                                                                                                                          2009 Copyright.  FC2 Female Condom®.  All Rights Reserved.